Estrogen Therapy May Reduce Menopause Brain Fog, UCLA Study Finds

Many women report memory lapses, difficulty concentrating, and slower thinking during menopause—a cluster of symptoms commonly referred to as “brain fog.” A new study from UCLA Health suggests that a hormone therapy combining estriol and progesterone may alleviate these cognitive complaints, offering a potential early treatment for a menopause‑related problem that currently lacks an FDA‑approved solution.

The research, published in the *Journal of Clinical Endocrinology & Metabolism*, involved a randomized, double‑blind trial of 120 postmenopausal women who experienced significant cognitive symptoms. Participants received either the estriol‑progesterone blend or a placebo for 12 weeks. Cognitive performance was assessed through standardized neuropsychological tests and self‑reported questionnaires. Those receiving the hormone therapy showed statistically significant improvements in working memory, attention, and processing speed compared with the placebo group, while adverse events were mild and comparable to the control arm.

Although the study’s duration was limited and the sample size modest, the findings point to a promising avenue for treating menopause‑related cognitive decline. Further large‑scale, long‑term trials will be needed to confirm efficacy, determine optimal dosing, and evaluate safety before the therapy could receive regulatory approval.